Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$100.58 - $112.38 $4.52 Million - $5.05 Million
-44,928 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$99.53 - $127.75 $2.11 Million - $2.71 Million
-21,217 Reduced 32.08%
44,928 $4.65 Million
Q3 2021

Nov 12, 2021

BUY
$122.75 - $135.17 $11,906 - $13,111
97 Added 0.15%
66,145 $8.29 Million
Q2 2021

Aug 13, 2021

BUY
$118.19 - $131.5 $24,347 - $27,089
206 Added 0.31%
66,048 $8.2 Million
Q1 2021

May 14, 2021

SELL
$111.18 - $119.74 $1,778 - $1,915
-16 Reduced 0.02%
65,842 $7.78 Million
Q4 2020

Feb 16, 2021

SELL
$100.57 - $117.14 $74,120 - $86,332
-737 Reduced 1.11%
65,858 $7.72 Million
Q3 2020

Nov 12, 2020

SELL
$90.13 - $108.78 $65,434 - $78,974
-726 Reduced 1.08%
66,595 $6.92 Million
Q2 2020

Aug 11, 2020

SELL
$84.11 - $103.33 $286,478 - $351,941
-3,406 Reduced 4.82%
67,321 $6.17 Million
Q1 2020

May 13, 2020

BUY
$72.92 - $121.3 $1.11 Million - $1.84 Million
15,189 Added 27.35%
70,727 $6.38 Million
Q4 2019

Feb 12, 2020

SELL
$104.49 - $114.54 $40,960 - $44,899
-392 Reduced 0.7%
55,538 $6.17 Million
Q3 2019

Nov 08, 2019

BUY
$98.02 - $111.18 $5.48 Million - $6.22 Million
55,930 New
55,930 $6.08 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $116B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Gluskin Sheff & Assoc Inc Portfolio

Follow Gluskin Sheff & Assoc Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gluskin Sheff & Assoc Inc, based on Form 13F filings with the SEC.

News

Stay updated on Gluskin Sheff & Assoc Inc with notifications on news.